Latifa Khalfaoui
About
In The Last Decade
Latifa Khalfaoui
15 papers receiving 351 citations
Hit Papers
Peers
Comparison fields: 5 of 57
- Physiology 279
- Pulmonary and Respiratory Medicine 163
- Immunology and Allergy 92
- Immunology 90
- Surgery 41
Countries citing papers authored by Latifa Khalfaoui
This map shows the geographic impact of Latifa Khalfaoui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Latifa Khalfaoui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Latifa Khalfaoui more than expected).
Fields of papers citing papers by Latifa Khalfaoui
This network shows the impact of papers produced by Latifa Khalfaoui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Latifa Khalfaoui. The network helps show where Latifa Khalfaoui may publish in the future.
Co-authorship network of co-authors of Latifa Khalfaoui
This figure shows the co-authorship network connecting the top 25 collaborators of Latifa Khalfaoui. A scholar is included among the top collaborators of Latifa Khalfaoui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Latifa Khalfaoui. Latifa Khalfaoui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 2 | |
| 3 | 4 | |
| 4 | 0 | |
| 5 | 4 | |
| 6 | 10 | |
| 7 | 6 | |
| 8 | 4 | |
| 9 | 19 | |
| 10 | 17 | |
| 11 | 11 | |
| 12 | 21 | |
| 13 | 3 | |
| 14 | Effect of tezepelumab on airway inflammatory cells, remodelling, and hyperresponsiveness in patients with moderate-to-severe uncontrolled asthma (CASCADE): a double-blind, randomised, placebo-controlled, phase 2 trial breakdown → | 225 |
| 15 | 28 | |
| 16 | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.